Table 6.
Principal medication use in patients adhering to study treatments.
| Day | Analgesics, n (%) | NSAIDsa, n (%) | Gastrointestinal, n (%) | None, n (%) | P value | ||
| Day 1 | .95 | ||||||
|
|
Control (n=51) | 19 (37.3) | 10 (19.6) | 4 (7.8) | 24 (47.1) |
|
|
|
|
Endocare (n=51) | 21 (41.2) | 13 (25.5) | 4 (7.8) | 23 (45.1) |
|
|
| Day 2 | .66 | ||||||
|
|
Control (n=50) | 17 (34.0) | 9 (18.0) | 4 (8.0) | 26 (52.0) |
|
|
|
|
Endocare (n=49) | 13 (26.5) | 12 (24.5) | 2 (4.1) | 27 (55.1) |
|
|
| Day 3 | .74 | ||||||
|
|
Control (n=29) | 11 (37.9) | 5 (17.2) | 3 (10.3) | 15 (51.8) |
|
|
|
|
Endocare (n=34) | 12 (35.3) | 6 (17.6) | 1 (2.9) | 19 (55.9) |
|
|
| Day 4 | .24 | ||||||
|
|
Control (n=21) | 8 (38.1) | 2 (9.5) | 1 (4.8) | 12 (57.1) |
|
|
|
|
Endocare (n=24) | 4 (16.7) | 7 (29.2) | 1 (4.2) | 15 (62.5) |
|
|
| Day 5 | .78 | ||||||
|
|
Control (n=18) | 5 (27.8) | 3 (16.7) | 3 (16.7) | 11 (61.1) |
|
|
|
|
Endocare (n=18) | 4 (22.2) | 2 (11.1) | 1 (5.6) | 13 (72.2) |
|
|
aNSAID: nonsteroidal anti-inflammatory drug.